RGLS logo

Regulus Therapeutics (RGLS) Operating Expenses

Annual Operating Expenses

$31.11 M
+$2.87 M+10.16%

December 31, 2023


Summary


Performance

RGLS Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSexpensesmetrics:

Quarterly Operating Expenses

$15.21 M
+$2.95 M+24.06%

September 30, 2024


Summary


Performance

RGLS Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

RGLS Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+10.2%+24.1%
3 y3 years+28.8%+112.0%
5 y5 years-33.6%+203.5%

RGLS Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+11.8%at high+131.5%
5 y5-yearat high+31.4%at high+241.6%
alltimeall time-62.4%+48.7%-39.2%+241.6%

Regulus Therapeutics Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$15.21 M(+24.1%)
Jun 2024
-
$12.26 M(+38.9%)
Mar 2024
-
$8.83 M(+6.3%)
Dec 2023
$31.11 M(+10.2%)
$8.30 M(+2.2%)
Sep 2023
-
$8.13 M(+11.1%)
Jun 2023
-
$7.32 M(-0.7%)
Mar 2023
-
$7.37 M(+6.3%)
Dec 2022
$28.24 M(+1.5%)
$6.93 M(-8.3%)
Sep 2022
-
$7.56 M(+5.4%)
Jun 2022
-
$7.17 M(+9.2%)
Mar 2022
-
$6.57 M(-5.6%)
Dec 2021
$27.82 M(+15.1%)
$6.96 M(-17.3%)
Sep 2021
-
$8.42 M(+26.8%)
Jun 2021
-
$6.64 M(+14.5%)
Mar 2021
-
$5.80 M(-3.8%)
Dec 2020
$24.16 M(+2.1%)
$6.03 M(-1.1%)
Sep 2020
-
$6.09 M(-6.2%)
Jun 2020
-
$6.50 M(+17.2%)
Mar 2020
-
$5.54 M(+24.4%)
Dec 2019
$23.67 M(-49.5%)
$4.45 M(-11.1%)
Sep 2019
-
$5.01 M(+6.9%)
Jun 2019
-
$4.69 M(-50.8%)
Mar 2019
-
$9.52 M(+18.9%)
Dec 2018
$46.84 M(-33.3%)
$8.00 M(-19.0%)
Sep 2018
-
$9.87 M(-26.1%)
Jun 2018
-
$13.36 M(-14.4%)
Mar 2018
-
$15.60 M(+13.7%)
DateAnnualQuarterly
Dec 2017
$70.20 M(-15.1%)
$13.72 M(-11.1%)
Sep 2017
-
$15.43 M(-27.7%)
Jun 2017
-
$21.34 M(+8.2%)
Mar 2017
-
$19.71 M(-0.3%)
Dec 2016
$82.70 M(+9.5%)
$19.76 M(+1.9%)
Sep 2016
-
$19.40 M(-10.5%)
Jun 2016
-
$21.67 M(-0.9%)
Mar 2016
-
$21.87 M(+20.0%)
Dec 2015
$75.52 M(+43.6%)
$18.22 M(+19.8%)
Sep 2015
-
$15.21 M(-39.2%)
Jun 2015
-
$25.02 M(+46.5%)
Mar 2015
-
$17.07 M(+24.1%)
Dec 2014
$52.58 M(+40.7%)
$13.75 M(+7.9%)
Sep 2014
-
$12.74 M(-7.3%)
Jun 2014
-
$13.75 M(+11.5%)
Mar 2014
-
$12.34 M(+21.9%)
Dec 2013
$37.37 M(+47.9%)
$10.12 M(+12.1%)
Sep 2013
-
$9.02 M(-4.5%)
Jun 2013
-
$9.45 M(+7.5%)
Mar 2013
-
$8.79 M(+16.5%)
Dec 2012
$25.27 M(+20.8%)
$7.54 M(+18.9%)
Sep 2012
-
$6.34 M(+8.1%)
Jun 2012
-
$5.87 M(+6.2%)
Mar 2012
-
$5.52 M(+5.4%)
Dec 2011
$20.93 M(-13.2%)
$5.24 M(+9.6%)
Sep 2011
-
$4.78 M
Dec 2010
$24.10 M
-

FAQ

  • What is Regulus Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Regulus Therapeutics?
  • What is Regulus Therapeutics annual operating expenses year-on-year change?
  • What is Regulus Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Regulus Therapeutics?
  • What is Regulus Therapeutics quarterly operating expenses year-on-year change?

What is Regulus Therapeutics annual total operating expenses?

The current annual operating expenses of RGLS is $31.11 M

What is the all time high annual operating expenses for Regulus Therapeutics?

Regulus Therapeutics all-time high annual total operating expenses is $82.70 M

What is Regulus Therapeutics annual operating expenses year-on-year change?

Over the past year, RGLS annual total operating expenses has changed by +$2.87 M (+10.16%)

What is Regulus Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of RGLS is $15.21 M

What is the all time high quarterly operating expenses for Regulus Therapeutics?

Regulus Therapeutics all-time high quarterly total operating expenses is $25.02 M

What is Regulus Therapeutics quarterly operating expenses year-on-year change?

Over the past year, RGLS quarterly total operating expenses has changed by +$2.95 M (+24.06%)